Cellular Dynamics International continues its progress in the stem cell market, as the company announced today that is has manufactured stem cell lines from two HLA “superdonors.”

According to a release, HLA superdonors are individuals whose genetic profiles make their cells or tissues more compatible for donation to unrelated patients.

“CDI is delighted to have produced two HLA superdonor iPSC lines that match 19 percent of the U.S. population, and over time we plan to build a bank that will match 95 percent of the U.S. population,” CEO Bob Palay said in a statement. “We expect this bank to prove to be an excellent resource for CDI and others to develop HLA-matched cell therapies.”

CDI’s HLA superdonor cell lines will be available for developing cellular therapies within a clinical setting.